achieved using a new proof-of-concept with the triple resonance
NMR technique. There are at least three advantages to our
method. The first is its selectivity. Because of the low natural
13
1
abundance of C, the H–13C–13C0 moiety renders the probe
extremely selective. The second advantage is that our probe is
signal activatable. Thus, our ‘‘switch-on’’ 1H MR probe is
otherwise silent and is rendered active only when a detectable
1H–13C–13C0 sequence is produced upon reacting with the
target. The third is versatility. The technique is not limited to
(sp2)
but can be applied to a variety of atom sequences
H–C–C0
such as H–C–N. This strategy of ‘‘atom arrangement’’ can be
used by chemists who can design and synthesize chemical
probes with a variety of atom sequences with different targets.
We demonstrated a new proof-of-concept for designing
activatable NMR probes. However, the present probe has
room to be improved further, especially in terms of reactivity,
conversion yield, and stability under physiological conditions.
Further challenge is now in progress in our laboratory.
This work was supported by NEXT program and Grant-
in-Aid Number 22685018 from JSPS and performed under the
Cooperative Research Program (IMCE, Kyushu University).
Notes and references
Fig. 3 (a) 1H (left) and 1H–{13C–13C0(sp2)} (right) spectra of Cm3-13C2
(1 mM) in CDCl3. (b) Triple resonance 1H NMR spectra of
HCm3-13C2 (100 mM) incubated with (lower) or without (upper) ꢀOCl
(180 mM) in phosphate buffer (pH 7.4, 1 mM) containing 0.1% DMF.
(c) Single (1H, upper) and triple resonance (lower) 1H NMR spectra of
HCm3-13C2 (100 mM) incubated with ꢀOCl (800 mM) in the presence
of pork muscle extract. (d) Fluorescence (left, excitation at 342 nm)
and triple resonance 1H NMR (right) spectra of HCm3-13C2 (100 mM)
after incubation with MPO/H2O2/Clꢀ or H2O2/Clꢀ.
1 For a recent review on ROS/RNS imaging probes, see: T. Nagano,
J. Clin. Biochem. Nutr., 2009, 45, 111–124 and references therein.
2 For a recent review on activatable probes, see: H. Kobayashi,
M. Ogawa, R. Alford, P. L. Choyke and Y. Urano, Chem. Rev.,
2010, 110, 2620–2640.
3 (a) K. Kundu, S. F. Knight, N. Willett, S. Lee, W. R. Taylor and
N. Murthy, Angew. Chem., Int. Ed., 2009, 48, 299–303;
(b) P. Panizzi, M. Nahrendorf, M. Wildgruber, P. Waterman,
J.-L. Figueiredo, E. Aikawa, J. McCarthy, R. Weissleder and
S. A. Hilderbrand, J. Am. Chem. Soc., 2009, 131, 15739–15744;
(c) D. Oushiki, H. Kojima, T. Terai, M. Arita, K. Hanaoka,
Y. Urano and T. Nagano, J. Am. Chem. Soc., 2010, 132, 2795–2801.
4 S. Gross, S. T. Gammon, B. L. Moss, D. Rauch, J. Harding,
J. W. Heinecke, L. Ratner and D. Piwnica-Worms, Nat. Med.
(N. Y.), 2009, 15, 455–461.
The signal was confirmed as aryl 1H of the Cm3-13C2 scaffold by
2D 1H–13C HSQC analysis (Fig. S5, ESIz), indicating actual
production of Cm3-13C2 or derivatives from HCm3-13C2 as
initially designed. Since the triple resonance technique greatly
improves selectivity, ꢀOCl is sensed by HCm3-13C2 even in crude
tissue extracts (lower spectrum in Fig. 3c). On the other hand,
detection of generated Cm3-13C2 or derivatives by conventional
1H NMR was unsuccessful because of spectral overlaps with a
5 For ROS-sensitive MR probes, see: (a) J. W. Chen, W. Pham,
R. Weissleder and A. Bogdanov, Magn. Reson. Med., 2004, 52,
1021–1028; (b) H. Utsumi, K. Yamada, K. Ichikawa, K. Sakai,
Y. Kinoshita, S. Matsumoto and M. Nagai, Proc. Natl. Acad. Sci.
U. S. A., 2006, 103, 1463–1468; (c) E. Rodrıguez, M. Nilges,
´
R. Weissleder and J. W. Chen, J. Am. Chem. Soc., 2010, 132, 168–177.
6 For a recent review on dual-modal probes, see: L. E. Jennings and
N. Long, Chem. Commun., 2009, 3511–3524 and references therein.
7 Recent examples on fluorescence-MR dual-modal probes, see:
(a) S. Mizukami, R. Takikawa, F. Sugihara, M. Shirakawa and
K. Kikuchi, Angew. Chem., Int. Ed., 2009, 48, 3641–3643; (b) Y. You,
E. Tomat, K. Hwang, T. Atanasijevic, W. Nam, A. P. Jasanoff and
S. J. Lippard, Chem. Commun., 2010, 46, 4139–4141.
1
variety of H signals derived from coexisting molecules (upper
spectrum in Fig. 3c). These results clearly indicate that
HCm3-13C2 functions as an off-to-on-switching 1H MR probe
for specific detection of ꢀOCl.
Finally, we applied the HCm3-13C2 probe to dual-mode
detection of myeloperoxidase (MPO) activity. MPO is a heme-
containing enzyme present mainly in neutrophils and mediates
the production of ꢀOCl from Clꢀ and H2O2 in the killing of
bacteria. As shown in Fig. 3d, HCm3-13C2 turns on its
fluorescence and 1H signal upon incubation with MPO/
H2O2/Clꢀ in an off-to-on manner. Although the possibility
that a fluorescent Cm3 scaffold was produced by direct
oxidation with MPO or reaction with 1O2 generated from
MPO cannot be excluded at this stage, this result clearly
indicated that our dual turn-on probe is also applicable to
sensing of the enzymatic MPO system.
8 L. E. Kay, M. Ikura, R. Tschudin and A. Bax, J. Magn. Reson.,
1990, 89, 496–514.
9 (a) J. K. Gard, P. C. C. Feng and W. C. Hutton, Xenobiotica, 1997,
27, 633–644; (b) W. C. Hutton, J. J. Likos, J. K. Gard and
J. R. Garbow, J. Labelled Compd. Radiopharm., 1998, 41, 87–95;
(c) J. K. Gard, W. C. Hutton, J. A. Baker, R. K. Singh and
P. C. C. Feng, Pestic. Sci., 1999, 55, 215–218.
10 K. Mizusawa, R. Igarashi, K. Uehira, Y. Takafuji, Y. Tabata,
H. Tochio, M. Shirakawa, S. Sando and Y. Aoyama, Chem. Lett.,
2010, 39, 926–928.
11 For ꢀOCl-selective fluorescence probes, see for example:
(a) K.-I. Setsukinai, Y. Urano, K. Kakinuma, H. J. Majima and
T. Nagano, J. Biol. Chem., 2003, 278, 3170–3175; (b) J. Shepherd,
S. A. Hilderbrand, P. Waterman, J. W. Heinecke, R. Weissleder
and P. Libby, Chem. Biol., 2007, 14, 1221–1231; (c) S. Kenmoku,
Y. Urano, H. Kojima and T. Nagano, J. Am. Chem. Soc., 2007,
129, 7313–7318; (d) ref. 3b.
In conclusion, our probe is the first dual activatable
fluorescence–1H MR probe for sensing of ꢀOCl. Especially, it
should be noted that the 1H MR-based turn-on sensing was
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 1565–1567 1567